Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 11 Cyclophosphamide 9 Magnetic Resonance Spectroscopy 8 pembrolizumab 6 Cisplatin 6 Bevacizumab 6 Radiosurgery 5 Oxaliplatin 5 Nivolumab 5 Irinotecan 5 Fluorouracil 5 Everolimus 5 Capecitabine 5 venetoclax 4 Vincristine 4 S 1 (combination) 4 Prednisone 4 Leucovorin 4 Etoposide 4 Drug Therapy 4 Doxorubicin 4 Azacitidine 4 fludarabine phosphate 3 fludarabine 3 Tacrolimus 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Rituximab 3 Radiotherapy 3 Radiation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × sotigalimab × Clear all

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡